DAZADROL

Details

Stereochemistry	RACEMIC
Molecular Formula	C15H14ClN3O
Molecular Weight	287.744
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC(C1=NCCN1)(C2=CC=C(Cl)C=C2)C3=NC=CC=C3

InChI

InChIKey=DITYEPYMBCHKLF-UHFFFAOYSA-N

InChI=1S/C15H14ClN3O/c16-12-6-4-11(5-7-12)15(20,14-18-9-10-19-14)13-3-1-2-8-17-13/h1-8,20H,9-10H2,(H,18,19)

HIDE SMILES / InChI

Molecular Formula	C15H14ClN3O
Molecular Weight	287.744
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4393004

Dazadrol is an antidepressant compound, developed by Schering Corp in the late 1960s. Dazadrol blocks uptake of noradrenaline and inhibits both basal and induced gastric acid secretion in the rat.

Originator

Approval Year

PubMed

Title	Date	PubMed
Blockade of noradrenaline uptake and inhibition of gastric acid secretion by 2-[p-chlorophenyl-2-(pyridyl)hydroxymethyl] imidazoline maleate (Sch-12650).	1970-05	4393004

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:18:12 GMT 2025` Edited by `admin` on `Mon Mar 31 18:18:12 GMT 2025`
Record UNII	9U27285V5R
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

DAZADROL

Official Name

English

.ALPHA.-(P-CHLOROPHENYL)-.ALPHA.-2-IMIDAZOLIN-2-YL-2-PYRIDINEMETHANOL

Preferred Name

English

dazadrol [INN]

Common Name

English

2-PYRIDINEMETHANOL, .ALPHA.-(4-CHLOROPHENYL)-.ALPHA.-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C265